108 related articles for article (PubMed ID: 21077431)
21. Analysis of 7-substituted sialic acid in some enterobacterial lipopolysaccharides.
Gamian A; Kenne L
J Bacteriol; 1993 Mar; 175(5):1508-13. PubMed ID: 8444811
[TBL] [Abstract][Full Text] [Related]
22. Resistance of Actinobacillus pleuropneumoniae to bactericidal antibody and complement is mediated by capsular polysaccharide and blocking antibody specific for lipopolysaccharide.
Ward CK; Inzana TJ
J Immunol; 1994 Sep; 153(5):2110-21. PubMed ID: 8051416
[TBL] [Abstract][Full Text] [Related]
23. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
Lagergård T; Frisk A; Purvèn M; Nilsson LA
Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
[TBL] [Abstract][Full Text] [Related]
24. The susceptibility of gram-negative rods and their adaptive forms resistant to colistine to the bactericidal action of sera.
Doroszkiewicz W; Cisowska A; Jankowski S; Koziorowski A; Murawski M
Acta Microbiol Pol; 1998; 47(3):275-81. PubMed ID: 9990711
[TBL] [Abstract][Full Text] [Related]
25. Human complement activation by smooth and rough Proteus mirabilis lipopolysaccharides.
Kaca W; Arabski M; Fudała R; Holmström E; Sjöholm A; Weintraub A; Futoma-Kołoch B; Bugla-Płoskońska G; Doroszkiewicz W
Arch Immunol Ther Exp (Warsz); 2009; 57(5):383-91. PubMed ID: 19707721
[TBL] [Abstract][Full Text] [Related]
26. Interaction of fluid phase C1/C1q and macrophage membrane-associated C1q with gram-negative bacteria.
Clas F; Euteneuer B; Stemmer F; Loos M
Behring Inst Mitt; 1989 Jul; (84):236-54. PubMed ID: 2552981
[TBL] [Abstract][Full Text] [Related]
27. Sialylation of Neisseria meningitidis lipooligosaccharide inhibits serum bactericidal activity by masking lacto-N-neotetraose.
Estabrook MM; Griffiss JM; Jarvis GA
Infect Immun; 1997 Nov; 65(11):4436-44. PubMed ID: 9353017
[TBL] [Abstract][Full Text] [Related]
28. Antibody-independent killing of gram-negative bacteria via the classical pathway.
Clas F; Loos M
Behring Inst Mitt; 1984 Nov; (76):59-74. PubMed ID: 6525148
[TBL] [Abstract][Full Text] [Related]
29. Bactericidal and opsonic activities of normal sheep serum against gram-negative bacteria.
Mittal KR; Ingram DG
Am J Vet Res; 1975 Aug; 36(08):1189-93. PubMed ID: 1098532
[TBL] [Abstract][Full Text] [Related]
30. Complement activation by Proteus mirabilis negatively charged lipopolysaccharides.
Kaca W; Literacka E; Sjöholm AG; Weintraub A
J Endotoxin Res; 2000; 6(3):223-34. PubMed ID: 11052177
[TBL] [Abstract][Full Text] [Related]
31. Swarming growth and resistance of Proteus penneri and Proteus vulgaris strains to normal human serum.
Kwil I; Kaźmierczak D; Różalski A
Adv Clin Exp Med; 2013; 22(2):165-75. PubMed ID: 23709372
[TBL] [Abstract][Full Text] [Related]
32. Role of lipopolysaccharide and complement in susceptibility of Escherichia coli and Salmonella typhimurium to non-immune serum.
Tomás JM; Ciurana B; Benedí VJ; Juarez A
J Gen Microbiol; 1988 Apr; 134(4):1009-16. PubMed ID: 3053980
[TBL] [Abstract][Full Text] [Related]
33. The requirement of specific anticapsular IgG for killing of Haemophilus influenzae by the alternative pathway of complement activation.
Tarr PI; Hosea SW; Brown EJ; Schneerson R; Sutton A; Frank MM
J Immunol; 1982 Apr; 128(4):1772-5. PubMed ID: 6977569
[TBL] [Abstract][Full Text] [Related]
34. [Bactericidal activity of human, swine and cattle serum against pseudomonas aeruginosa strains].
Wolska K; Bukowski K; Anusz Z; Jakubczak A
Med Dosw Mikrobiol; 1999; 51(3-4):339-45. PubMed ID: 10803263
[TBL] [Abstract][Full Text] [Related]
35. Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS).
Morrison DC; Kline LF
J Immunol; 1977 Jan; 118(1):362-8. PubMed ID: 318670
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the susceptibility of Pseudomonas aeruginosa to complement-mediated killing: role of antibodies to the rough lipopolysaccharide on serum-sensitive strains.
Schiller NL
Infect Immun; 1988 Mar; 56(3):632-9. PubMed ID: 3125110
[TBL] [Abstract][Full Text] [Related]
37. Sensitivity of Shigella strains to bactericidal activity of human serum. I. Participation of two independently active mechanisms in bactericidal action against Shigella sonnei phase II.
Mokracka-Latajka G; Grzybek-Hryncewicz K; Jankowski S
Acta Microbiol Pol; 1990; 39(3-4):111-6. PubMed ID: 1715644
[TBL] [Abstract][Full Text] [Related]
38. The C4 and C2 but not C1 components of complement are responsible for the complement activation triggered by the Ra-reactive factor.
Ji YH; Matsushita M; Okada H; Fujita T; Kawakami M
J Immunol; 1988 Dec; 141(12):4271-5. PubMed ID: 3058802
[TBL] [Abstract][Full Text] [Related]
39. Role of lipopolysaccharide and complement in susceptibility of Klebsiella pneumoniae to nonimmune serum.
Ciurana B; Tomás JM
Infect Immun; 1987 Nov; 55(11):2741-6. PubMed ID: 3312009
[TBL] [Abstract][Full Text] [Related]
40. The factor C3 conversion in human complement by smooth Shigella flexneri lipopolysaccharides.
Fudała R; Doroszkiewicz W; Niedbach J; Gamian A; Weintraub A; Kaca W
Acta Microbiol Pol; 2003; 52(1):45-52. PubMed ID: 12916727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
